When did jynarque went loe?

When did Jynarque go “Loe” (LOE/lose exclusivity)?

I can’t determine what “loe” means in your question, because it could refer to different exclusivity events (for example, “LOE” often means “loss of exclusivity,” but the exact date depends on which exclusivity or patent you mean).

What I can do right away:
1) If you mean “loss of exclusivity” for Jynarque (to allow generic or other competition), tell me which country (U.S. is most common) and whether you mean patent expiry or exclusivity expiry.
2) If you share what “LOE” stands for in your context (or paste the sentence you’re looking at), I’ll match it to the correct date.

What “LOE” usually refers to for drugs like Jynarque

“Loss of exclusivity” commonly refers to the point when a brand loses protection that previously blocked generic entry (for example, the end of regulatory exclusivity and/or relevant patents). The exact “LOE date” can differ depending on whether it’s:
- U.S. patent expiry vs. FDA marketing exclusivity, or
- an extension (pediatric, forfeiture, settlements, etc.), or
- a specific strength/formulation.

Next step

Reply with either:
- “U.S. LOE date” (and confirm that “loe” = loss of exclusivity), or
- a link or screenshot text where you saw “loe,”

and I’ll provide the specific date.

Sources: none cited.